EGF and neoplasm: In turn, the TAMs can block antitumor immune responses and accelerate tumor progression by increasing the expression of cytokines and chemokines, such as platelet-derived growth factor (PDGF), epidermal growth factor (EGF), and insulin-like growth factor (IGF) (23).